Medicare, oncology, radiation and imaging reimbursement issues; medicare physician payments; Oncology payment disparities in Medicare.; Health information technology; application of the sequester to cancer drug reimbursement; prompt pay discount; safety and security of the prescription drug supply chain.
2025 · 4th Quarter (Oct 1 - Dec 31)
MCKESSON CORPATION AND ITS AFFILIATE US ONCOLOGY (FORMERLY US ONCOLOGY)
Filed by STANTON PARK GROUP.
Open official filingSource-reported fields
Filing overview
- Type
- 4th Quarter - Report
- Posted
- Jan 20, 2026
- Income
- $60,000.00
- Expenses
- Not reported
- Registrant
- STANTON PARK GROUP
- Filing UUID
- 731112ab-a263-4a13-a703-cdf526426da4
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
H.R.2484, Seniors Access to Critical Medications Act of 2025
Literal federal measure citations: H.R.2484
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.